Hasil Pencarian - Zi-Wei Tu
- Menampilkan 1 - 6 hasil dari 6
-
1
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma oleh Meng-Xia Zhang, Li Wang, Lei Zeng, Zi-Wei Tu
Diterbitkan 2021-03-01
Artikel -
2
LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma oleh Meng-Xia Zhang, Li Wang, Lei Zeng, Zi-Wei Tu
Diterbitkan 2021-02-01
Artikel -
3
ZBTB7A functioned as an oncogene in colorectal cancer oleh Li Wang, Meng-Xia Zhang, Mei-Fang Zhang, Zi-Wei Tu
Diterbitkan 2020-11-01
Artikel -
4
Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Canc... oleh Bing-Qing Xu, Zi-Wei Tu, Ya-Lan Tao, Zhi-Gang Liu, Xiao-Hui Li, Wei Yi, Chang-Bing Jiang, Yun-Fei Xia
Diterbitkan 2016-04-01
Artikel -
5
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyResearch in context oleh Xi Ding, Yi-Jun Hua, Xiong Zou, Xiao-Zhong Chen, Xi-Mei Zhang, Bei Xu, Yan-Feng Ouyang, Zi-Wei Tu, Hui-Feng Li, Chong-Yang Duan, Wei-Jing Zhang, Rui You, You-Ping Liu, Yong-Long Liu, Qi Yang, Pei-Yu Huang, Shu-Ni Wang, Jia Fan, Ming-Yuan Chen
Diterbitkan 2023-07-01
Artikel -
6
The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcino... oleh Rui Zou, Rui Zou, Rui Zou, Jing-Jing Yuan, Jing-Jing Yuan, Jing-Jing Yuan, Qiang Li, Jian-Wu Ding, Jian-Wu Ding, Bing Liao, Zi-Wei Tu, Rong-Huan Hu, Rong-Huan Hu, Dan Gong, Dan Gong, Jia-Li Hu, Jia-Li Hu, Lei Zeng, Lei Zeng, Lei Zeng
Diterbitkan 2021-02-01
Artikel